๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetic studies of pentylenetetrazol in dogs

โœ Scribed by H. W. Jun

Publisher
John Wiley and Sons
Year
1976
Tongue
English
Weight
420 KB
Volume
65
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacokinetic studies with atenolol in
Pharmacokinetic studies with atenolol in the dog
โœ Dr. James McAinsh; Brian F. Holmes ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 445 KB ๐Ÿ‘ 2 views

The pharmacokinetics of the cardioselective ,!hadrenoreceptor blocking agent atenolol have been determined following intravenous and oral dosing t o the dog. After intravenous administration at 200mg the blood levels of parent drug were found to decay tri-exponentially with a final elimination phase

Pharmacokinetics of tiazofurin in dogs
Pharmacokinetics of tiazofurin in dogs
โœ E. K. Obeng; J. J. Vallner; D. E. Cadwallader; Dr R. L. Tackett ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 332 KB ๐Ÿ‘ 1 views

The pharmacokinetics of total and free tiazofurin, an antineoplastic agent, was studied in healthy mongrel dogs following intravenous and oral administration of the drug. The free fraction of tiazofurin was obtained from plasma by an ultrafiltration technique using a micropartition system. Total and

Pharmacokinetics of indapamide in dogs
Pharmacokinetics of indapamide in dogs
โœ Peter E. Grebow; Jo A. Treitman ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 329 KB
Pharmacokinetics of pyridostigmine in do
Pharmacokinetics of pyridostigmine in dogs
โœ T. Taylor; D. R. Hawkins; T. J. Forrest; H. Chung ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 457 KB
Pharmacokinetics of reboxetine enantiome
Pharmacokinetics of reboxetine enantiomers in the dog
โœ E. Frigerio; A. Benecchi; G. Brianceschi; C. Pellizzoni; I. Poggesi; M. Strolin ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 139 KB ๐Ÿ‘ 2 views

Reboxetine, (RS)-2-[(RS)-alpha-(2-ethoxyphenoxy)benzyl]morpholine methanesulphonate, is a racemic compound and consists of a mixture of the (R,R)- and (S,S)-enantiomers. The pharmacokinetics of reboxetine enantiomers were determined in a crossover study in three male beagle dogs. Each animal receive